Browse by Tags

Rosetta Genomics Interview – microRNA for Diagnosing Lung Cancer Tumors

Tests to detect cancer of the unknown primary Rosetta Genomics – Today I had the opportunity to speak with and interview Ronen Tamir, Chief Commercialization Officer, at Rosetta to find out how microRNA is helping diagnose and treat cancer. ...

Published Thu, Jan 01 2009 2:54 AM by The Medical Quack

Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, Genomics, Biotech, Cancer, Cancer Treatment, Lung Cancer, Rosetta, microRNA, green, microarray, Cancer Tests

In Silicon Valley, Venture Capitalists Turn Cautious – Now thinking about personalized healthcare investments…

Well this might end up being a good move here as there’s much to gain. At least invest in something that has the potential to improve and save lives rather than to over deluge us with more social software. Don’t misunderstand here, I use and...

Published Tue, Jan 01 2009 3:33 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, personalized medicine, healthcare, Biotech, Cancer, R and D, Start Ups, Venture Capital, Web 2.0

New small blood scanner detects indicators of cancer - start up company to develop

The product can locate cancer-associated proteins in a blood serum sample in less than an hour, and with much greater sensitivity than existing commercial devices. It detects multiple proteins at one time too, and by detecting multiple biomarkers...

Published Thu, Dec 12 2008 2:18 AM by The Medical Quack

Filed under: Medically Related, Technology, healthcare, Biotech, Cancer, Blood Tests, R and D, Biomarkers, Stanford University, Molecular Science, markers

Favrille Biotech and MyMedicalRecords.com, Inc. Announce Merger Agreement

This is a real interesting merger with a biotech company patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system merging with a company that provides personal health records, both companies from California...

Published Mon, Nov 11 2008 8:34 PM by The Medical Quack

Filed under: Medically Related, Technology, healthcare, Biotech, PHR, Google Health, Cancer, clinical trials, Personal Health Records, R and D

Michael Milken and Muhammad Yunus – Discuss Healthcare and the Economy with Charlie Rose

This interview from Charlie Roses touches on many items and Nobel Prize Winner Muhammad Yunus adds what he has been able to accomplish in his part of the world in Bangladesh and how some of those principles can be applied here, coming together of both...

Published Tue, Oct 10 2008 2:58 PM by The Medical Quack

Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, healthcare, Biotech, Cancer, Pharmaceuticals, R and D, Economy, Banking, Milken Institute, Mahammed Yunus, Milken, Charlie Rose

Getting personal with cancer therapy – Personalized Medicine

It is here but evolving slower than what all of us might like to see, and in many areas it is still so much of a “Science” but as developments occur through biotech we are seeing some amazing results. There’s also the bridging of the gap with bringing...

Published Sun, Oct 10 2008 1:05 PM by The Medical Quack

Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Pharma, Biotech, Cancer, tumors, Genentech, Herceptin, cancer vaccine

Business Intelligence Study Finds Pharma Pricing Research Being Conducted Earlier

In other words, this is called Business Intelligence. Lots of it out there to choose from and one from Microsoft specifically related to hospital management and budgets. Before the demise of Wall Street it wasn’t too long ago that I posted...

Published Fri, Sep 09 2008 1:34 PM by The Medical Quack

Filed under: Medically Related, Technology, Other Items of Interest, My Commentaries, Pharma, Biotech, Cancer, Business Intelligence, R and D, Wall Street, Pricing

The Changing Face of Research and Development with big Pharma

Many of the generic manufacturers started years back with knock off drugs to sell locally in India, but now the game is changing to where US Pharma is using some of the talent, which costs less than R and D individuals here in the states, to further develop...

Published Fri, Sep 09 2008 6:58 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Biotech, Cancer, FDA, Budgets, R and D, Alzheimers, Outsourcing

Stand Up To Cancer - Friday September 5, 2008 - 8:00 EST

You can set up a log in and donate today. Click here for details. As I had posted in a story a couple days ago, the bar has risen for venture capitalist investments, it is still there, but perhaps a little tougher to get, and with government...

Published Sat, Aug 08 2008 11:42 PM by The Medical Quack

Filed under: Medically Related, Other Items of Interest, My Commentaries, healthcare, Biotech, Cancer, Research, Charity, Stand up to Cancer, Donation, Entertainment, Donation Drive, Cancer Cures

Patients Fear Their Rapport With Genentech Is in Danger

Right now according to the Wall Street Journal, patients who have enjoyed an open relationship are worried that this could all change under management from Roche. Is bigger always better? Recently in the news Genentech is not happy with the...

Published Thu, Aug 08 2008 1:05 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Pharma, Biotech, Cancer, clinical trials, Genentech, Rocha

Roche snaps up Arius platform for $189M

Mark up one more purchase for Roche this week. Pharmaceutical companies are looking for for biotech purchases and Roche is not wasting one moment this week. Arius fits right in with current ongoing cancer research. Who will be on the...

Published Wed, Jul 07 2008 7:04 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Biotech, Cancer, Roche

Pond Scum – Cancer Therapy?

Yes there is a grant for this research of around 3 million. Cyanobacteria samples (the pond scum) will be collected and grown. Blue green algae is being studied as a potential alternative to some chemotherapy treatments. Once more breaking...

Published Tue, Jul 07 2008 9:55 AM by The Medical Quack

Filed under: Medically Related, Technology, healthcare, Biotech, Cancer, Pond Scum

Cell Therapeutics running out of cash - Biotech

One Biotech looking for money with their focus on cancer treating drugs in various stages of clinical trials. BD Seattle-based Cell Therapeutics is sending out an SOS signal to investors. "We have an immediate need to raise additional...

Published Mon, Jul 07 2008 11:44 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Biotech, Cancer, Research and Development

Test can find tiny tumor level in blood – Nanotechnology and Personalized Medicine combined - Breakthrough

One scientist commented that just being able to do a blood test to find tumors is a huge breakthrough and opens up more new avenues instead of having to rely only on biopsies and CAT scans. “ If the number of cancer cells in the bloodstream falls...

Published Thu, Jul 07 2008 4:23 PM by The Medical Quack

Filed under: Medically Related, Technology, personalized medicine, Biotech, Cancer, Breakthroughs, Blood Tests

Grassley's War on Cancer Patients

Good insight and commentary here from the "inside" track...are members of Congress helping or stalling the progression of the FDA... will the Biotechs be able to develop and withstand some of the stringencies and additional methodologies to...

Published Thu, May 05 2008 1:29 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Biotech, Cancer, FDA

Syndication

Recent Posts

Tags

Archives